Wells Fargo Downgrades Akcea Therapeutics, Inc. (AKCA) to Equal Weight, Following Acquisition
Tweet Send to a Friend
Wells Fargo analyst Jim Birchenough downgraded Akcea Therapeutics, Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE